Tuning CRISPR for the Brain's Nondividing Cells

Genome editing is poised to revolutionise the treatment of genetic diseases, yet a lack of control over DNA repair has hindered its full potential. This is particularly true for nondividing cells like neurons, where the mechanics of repair have remained largely a mystery. Recent research using human induced pluripotent stem cells has finally shed light on this process.

The study reveals that CRISPR editing outcomes differ dramatically in neurons compared to genetically identical dividing cells. Neurons take significantly longer to resolve Cas9-induced damage and rely on non-canonical repair factors—specialised proteins distinct from the standard repair toolkit—to finish the job. By using chemical or genetic tweaks to manipulate this unique response, researchers successfully directed DNA repair toward specific, desired outcomes.

This breakthrough extends beyond the brain, allowing for more precise editing in cardiomyocytes (heart muscle cells) and primary T cells. These findings uncover vital opportunities for refining therapeutic editing in clinically relevant tissues that do not actively divide.